Climb Bio annual operating expenses
2020
2021
2022
2023
2024
2025
Climb Bio Operating Expenses Growth & History (CLYM)
Climb Bio's operating expenses was $67.9M for fiscal 2025.
View full Climb Bio company overviewClimb Bio annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $67.9M | −$14.1M | −17.24% |
| 2024 | 2024-12-31 | $82.0M | $41.7M | +103.65% |
| 2023 | 2023-12-31 | $40.3M | −$4.9M | −10.77% |
| 2022 | 2022-12-31 | $45.1M | $9.5M | +26.53% |
| 2021 | 2021-12-31 | $35.7M | $14.7M | +70.48% |
| 2020 | 2020-12-31 | $20.9M | — | — |
Climb Bio quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $15.4M | $4.7M | +43.85% |
| Q1 2026 | 2026-03-31 | $15.2M | −$7.8M | −33.92% |
| Q4 2025 | 2025-12-31 | $19.3M | $8.4M | +76.85% |
| Q3 2025 | 2025-09-30 | $14.9M | $3.2M | +26.93% |
| Q2 2025 | 2025-06-30 | $10.7M | −$45.7M | −81.06% |
| Q1 2025 | 2025-03-31 | $23.0M | $20.0M | +665.99% |
| Q4 2024 | 2024-12-31 | $10.9M | $5.8M | +113.02% |
| Q3 2024 | 2024-09-30 | $11.7M | $6.7M | +134.59% |
| Q2 2024 | 2024-06-30 | $56.4M | $49.7M | +739.62% |
| Q1 2024 | 2024-03-31 | $3.0M | −$20.4M | −87.18% |
| Q4 2023 | 2023-12-31 | $5.1M | −$4.4M | −46.39% |
| Q3 2023 | 2023-09-30 | $5.0M | −$3.7M | −42.83% |
| Q2 2023 | 2023-06-30 | $6.7M | −$7.0M | −51.00% |
| Q1 2023 | 2023-03-31 | $23.4M | $10.3M | +78.48% |
| Q4 2022 | 2022-12-31 | $9.6M | −$1.1M | −10.74% |
| Q3 2022 | 2022-09-30 | $8.7M | −$635,000 | −6.77% |
| Q2 2022 | 2022-06-30 | $13.7M | $5.0M | +57.36% |
| Q1 2022 | 2022-03-31 | $13.1M | $6.3M | +90.90% |
| Q4 2021 | 2021-12-31 | $10.7M | — | — |
| Q3 2021 | 2021-09-30 | $9.4M | $7.1M | +315.36% |
| Q2 2021 | 2021-06-30 | $8.7M | $7.1M | +441.48% |
| Q1 2021 | 2021-03-31 | $6.9M | — | — |
| Q3 2020 | 2020-09-30 | $2.3M | — | — |
| Q2 2020 | 2020-06-30 | $1.6M | — | — |
Climb Bio operating expenses trends
Over the last five fiscal years, Climb Bio's operating expenses increased from $20.9M to $67.9M, a change of $47.0M. The latest reported quarter, Q2 2026, shows $15.4M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Climb Bio source filings ↗